-
Clinical Endpoints Study for HERPES GENITALIS
Regular price From €2.000,00 EURRegular priceUnit price per -
Expert mapping Study for HERPES GENITALIS
Regular price From €1.500,00 EURRegular priceUnit price per -
Safety Shield Study for LETERMOVIR
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for BRIVUDINE
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for CIDOFOVIR
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for FOSCARNET
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for DOCOSANOL
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for PENCICLOVIR
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for FAMCICLOVIR
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for VALACYCLOVIR
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for ACYCLOVIR
Regular price From €800,00 EURRegular priceUnit price per
Explore our exclusive study series
-
Safety Shield Studies
Safety Shield uses AI to streamline pharmacovigilance, reducing specialist workload by 80%...
-
Expert Mapping Studies
Expert Mapping Reports cut screening time by 10 days and reduce failed...
-
Clinical Endpoints Studies
This targeted analysis delivers a robust assessment of clinical endpoints tailored to...
